Physician profile
Matthew D Pepe
NPI 1083653398
$24,024.98
in general payments reported to CMS, 2019-2025
17 companies · $18K in 2025
The $18K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,637 · 2020: $110 · 2021: $704 · 2022: $146 · 2023: $429 · 2024: $3,364 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $5,882 · Food and Beverage: $1,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,968.75 |
| Travel and Lodging | $5,881.85 |
| Food and Beverage | $1,576.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $9,738.35 | 2019-2025 | Real Intelligence, Visionaire, Aetos Shoulder System |
| Globus Medical, INC. | $8,796.00 | 2024-2025 | Captivate Vl |
| Shoulder Innovations, INC. | $2,498.18 | 2024-2025 | Inset System |
| Wright Medical Technology, INC. | $810.03 | 2019 | |
| Stryker Corporation | $800.50 | 2019-2025 | Blueprint Patient Specific Instrumentation, Triathlon, Aequalis Perform |
| Depuy Synthes Sales INC. | $662.14 | 2019-2023 | Na, Vapr, Rigidloop |
| Eclipse Technology Solutions INC. | $126.11 | 2024-2025 | |
| Linvatec Corporation | $124.88 | 2023 | Biobrace 23mm |
| Fx Shoulder Solutions, INC | $123.18 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $89.57 | 2021 | |
| Arthrex, INC. | $59.30 | 2025 | |
| Bioventus LLC | $48.11 | 2024 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $43.24 | 2019-2022 | |
| Liberty Surgical INC. | $43.00 | 2021 | |
| Ferring Pharmaceuticals INC. | $25.40 | 2019-2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $23.72 | 2025 | Maci |
| Davol INC. | $13.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Pepe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.